Stock Analysis on Net
Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Analysis of Solvency Ratios
Quarterly Data

Beginner level


Solvency Ratios (Summary)

Medtronic PLC, solvency ratios (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
Debt Ratios
Debt to equity 0.49 0.49 0.51 0.52 0.51 0.50 0.50 0.50 0.51 0.57 0.56 0.67 0.66 0.65 0.65 0.63 0.60 0.71 0.69 0.67 0.68 1.43 0.70 0.67
Debt to capital 0.33 0.33 0.34 0.34 0.34 0.33 0.34 0.33 0.34 0.36 0.36 0.40 0.40 0.39 0.39 0.39 0.38 0.41 0.41 0.40 0.40 0.59 0.41 0.40
Debt to assets 0.27 0.28 0.28 0.29 0.28 0.28 0.28 0.28 0.28 0.30 0.31 0.34 0.34 0.33 0.33 0.33 0.31 0.35 0.34 0.34 0.34 0.52 0.35 0.34
Financial leverage 1.79 1.79 1.80 1.81 1.79 1.78 1.78 1.79 1.80 1.91 1.84 1.98 1.98 1.98 1.96 1.94 1.92 2.02 2.01 1.98 2.00 2.74 2.00 1.95
Coverage Ratios
Interest coverage 4.71 4.12 3.84 3.76 4.60 6.40 5.94 6.14 5.95 5.81 5.77 5.34 5.21 4.35 4.49 4.24 4.13 3.81 4.08 4.82 6.23

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

Solvency ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. Medtronic PLC’s debt to equity ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Medtronic PLC’s debt to capital ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. Medtronic PLC’s debt to assets ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. Medtronic PLC’s financial leverage ratio decreased from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Solvency ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Medtronic PLC’s interest coverage ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Debt to Equity

Medtronic PLC, debt to equity calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
Selected Financial Data (US$ in millions)
Current debt obligations 2,776  844  875  1,458  838  1,356  1,343  1,545  2,058  2,902  3,131  8,058  7,520  6,226  3,367  1,947  993  2,153  2,158  1,850  2,434  2,185  3,970  2,477 
Long-term debt 22,021  24,732  24,752  24,804  24,486  23,674  23,673  23,678  23,699  25,918  25,941  25,953  25,921  25,923  29,010  30,124  30,247  33,681  33,690  33,709  33,752  26,641  9,708  10,323 
Total debt 24,797  25,576  25,627  26,262  25,324  25,030  25,016  25,223  25,757  28,820  29,072  34,011  33,441  32,149  32,377  32,071  31,240  35,834  35,848  35,559  36,186  28,826  13,678  12,800 
 
Shareholders’ equity 50,737  51,808  50,578  50,363  50,091  49,829  49,607  50,224  50,720  50,234  51,469  50,672  50,294  49,387  50,186  50,824  52,063  50,816  52,269  52,809  53,230  20,173  19,438  19,248 
Solvency Ratio
Debt to equity1 0.49 0.49 0.51 0.52 0.51 0.50 0.50 0.50 0.51 0.57 0.56 0.67 0.66 0.65 0.65 0.63 0.60 0.71 0.69 0.67 0.68 1.43 0.70 0.67
Benchmarks
Debt to Equity, Competitors2
Becton, Dickinson & Co. 0.78 1.01 0.92 0.92 0.94 0.97 0.98 1.02 1.04 1.08 1.07 1.46 1.51 1.29 1.45 1.51 1.48 1.63 1.77 1.79 1.82 1.93 2.00
Boston Scientific Corp. 0.61 0.75 0.72 1.12 1.01 1.00 0.81 0.80 0.84 0.82 0.80 0.75 0.81 0.78 0.81 0.84 0.87 0.88 0.90 0.91 0.78 0.66
Danaher Corp. 0.62 0.84 0.72 0.54 0.32 0.30 0.35 0.38 0.42 0.39 0.40 0.43 0.47 0.50 0.53 0.36 0.59 0.51 0.54 0.65 0.13 0.14
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Stryker Corp. 1.01 0.80 0.87 0.68 0.71 0.72 0.84 0.73 0.76 0.86 0.72 0.69 0.73 0.74 0.72 0.73 0.84 0.85 0.47 0.41 0.41 0.42
Thermo Fisher Scientific Inc. 0.71 0.70 0.60 0.58 0.66 0.66 0.69 0.70 0.73 0.80 0.83 0.89 0.75 0.78 0.77 0.87 0.67 0.72 0.59 0.64 0.68 0.75
UnitedHealth Group Inc. 0.72 0.91 0.71 0.82 0.80 0.74 0.71 0.67 0.73 0.75 0.66 0.65 0.74 0.81 0.86 0.88 0.91 0.96 0.95 0.96 0.55 0.58

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

1 Q4 2020 Calculation
Debt to equity = Total debt ÷ Shareholders’ equity
= 24,797 ÷ 50,737 = 0.49

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. Medtronic PLC’s debt to equity ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Debt to Capital

Medtronic PLC, debt to capital calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
Selected Financial Data (US$ in millions)
Current debt obligations 2,776  844  875  1,458  838  1,356  1,343  1,545  2,058  2,902  3,131  8,058  7,520  6,226  3,367  1,947  993  2,153  2,158  1,850  2,434  2,185  3,970  2,477 
Long-term debt 22,021  24,732  24,752  24,804  24,486  23,674  23,673  23,678  23,699  25,918  25,941  25,953  25,921  25,923  29,010  30,124  30,247  33,681  33,690  33,709  33,752  26,641  9,708  10,323 
Total debt 24,797  25,576  25,627  26,262  25,324  25,030  25,016  25,223  25,757  28,820  29,072  34,011  33,441  32,149  32,377  32,071  31,240  35,834  35,848  35,559  36,186  28,826  13,678  12,800 
Shareholders’ equity 50,737  51,808  50,578  50,363  50,091  49,829  49,607  50,224  50,720  50,234  51,469  50,672  50,294  49,387  50,186  50,824  52,063  50,816  52,269  52,809  53,230  20,173  19,438  19,248 
Total capital 75,534  77,384  76,205  76,625  75,415  74,859  74,623  75,447  76,477  79,054  80,541  84,683  83,735  81,536  82,563  82,895  83,303  86,650  88,117  88,368  89,416  48,999  33,116  32,048 
Solvency Ratio
Debt to capital1 0.33 0.33 0.34 0.34 0.34 0.33 0.34 0.33 0.34 0.36 0.36 0.40 0.40 0.39 0.39 0.39 0.38 0.41 0.41 0.40 0.40 0.59 0.41 0.40
Benchmarks
Debt to Capital, Competitors2
Becton, Dickinson & Co. 0.44 0.50 0.48 0.48 0.48 0.49 0.50 0.51 0.51 0.52 0.52 0.59 0.60 0.56 0.59 0.60 0.60 0.62 0.64 0.64 0.64 0.66 0.67
Boston Scientific Corp. 0.38 0.43 0.42 0.53 0.50 0.50 0.45 0.44 0.46 0.45 0.44 0.43 0.45 0.44 0.45 0.46 0.47 0.47 0.47 0.48 0.44 0.40
Danaher Corp. 0.38 0.46 0.42 0.35 0.24 0.23 0.26 0.28 0.29 0.28 0.29 0.30 0.32 0.33 0.35 0.26 0.37 0.34 0.35 0.39 0.12 0.12
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Stryker Corp. 0.50 0.44 0.46 0.41 0.42 0.42 0.46 0.42 0.43 0.46 0.42 0.41 0.42 0.43 0.42 0.42 0.46 0.46 0.32 0.29 0.29 0.30
Thermo Fisher Scientific Inc. 0.42 0.41 0.37 0.37 0.40 0.40 0.41 0.41 0.42 0.44 0.45 0.47 0.43 0.44 0.44 0.47 0.40 0.42 0.37 0.39 0.40 0.43
UnitedHealth Group Inc. 0.42 0.48 0.41 0.45 0.44 0.43 0.41 0.40 0.42 0.43 0.40 0.39 0.43 0.45 0.46 0.47 0.48 0.49 0.49 0.49 0.35 0.37

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

1 Q4 2020 Calculation
Debt to capital = Total debt ÷ Total capital
= 24,797 ÷ 75,534 = 0.33

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Medtronic PLC’s debt to capital ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Debt to Assets

Medtronic PLC, debt to assets calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
Selected Financial Data (US$ in millions)
Current debt obligations 2,776  844  875  1,458  838  1,356  1,343  1,545  2,058  2,902  3,131  8,058  7,520  6,226  3,367  1,947  993  2,153  2,158  1,850  2,434  2,185  3,970  2,477 
Long-term debt 22,021  24,732  24,752  24,804  24,486  23,674  23,673  23,678  23,699  25,918  25,941  25,953  25,921  25,923  29,010  30,124  30,247  33,681  33,690  33,709  33,752  26,641  9,708  10,323 
Total debt 24,797  25,576  25,627  26,262  25,324  25,030  25,016  25,223  25,757  28,820  29,072  34,011  33,441  32,149  32,377  32,071  31,240  35,834  35,848  35,559  36,186  28,826  13,678  12,800 
 
Total assets 90,689  92,822  91,053  91,268  89,694  88,730  88,150  89,721  91,393  95,800  94,458  100,250  99,816  97,578  98,406  98,601  99,782  102,706  104,945  104,626  106,685  55,233  38,780  37,554 
Solvency Ratio
Debt to assets1 0.27 0.28 0.28 0.29 0.28 0.28 0.28 0.28 0.28 0.30 0.31 0.34 0.34 0.33 0.33 0.33 0.31 0.35 0.34 0.34 0.34 0.52 0.35 0.34
Benchmarks
Debt to Assets, Competitors2
Becton, Dickinson & Co. 0.35 0.40 0.37 0.37 0.39 0.39 0.40 0.40 0.41 0.42 0.41 0.50 0.51 0.43 0.45 0.45 0.46 0.48 0.49 0.48 0.49 0.49 0.55
Boston Scientific Corp. 0.31 0.34 0.33 0.41 0.39 0.39 0.34 0.33 0.33 0.30 0.29 0.30 0.32 0.31 0.30 0.31 0.30 0.32 0.31 0.32 0.30 0.26
Danaher Corp. 0.31 0.38 0.35 0.29 0.19 0.18 0.20 0.22 0.24 0.22 0.23 0.24 0.25 0.26 0.27 0.20 0.28 0.26 0.27 0.30 0.09 0.09
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Stryker Corp. 0.41 0.36 0.37 0.32 0.32 0.33 0.36 0.33 0.33 0.36 0.33 0.34 0.35 0.35 0.34 0.34 0.37 0.38 0.25 0.22 0.21 0.21
Thermo Fisher Scientific Inc. 0.35 0.34 0.30 0.30 0.33 0.33 0.34 0.34 0.35 0.37 0.37 0.39 0.36 0.37 0.36 0.39 0.33 0.35 0.31 0.32 0.34 0.35
UnitedHealth Group Inc. 0.24 0.27 0.23 0.26 0.25 0.24 0.24 0.22 0.23 0.23 0.23 0.21 0.23 0.25 0.27 0.27 0.28 0.29 0.29 0.29 0.20 0.20

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

1 Q4 2020 Calculation
Debt to assets = Total debt ÷ Total assets
= 24,797 ÷ 90,689 = 0.27

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. Medtronic PLC’s debt to assets ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Financial Leverage

Medtronic PLC, financial leverage calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
Selected Financial Data (US$ in millions)
Total assets 90,689  92,822  91,053  91,268  89,694  88,730  88,150  89,721  91,393  95,800  94,458  100,250  99,816  97,578  98,406  98,601  99,782  102,706  104,945  104,626  106,685  55,233  38,780  37,554 
Shareholders’ equity 50,737  51,808  50,578  50,363  50,091  49,829  49,607  50,224  50,720  50,234  51,469  50,672  50,294  49,387  50,186  50,824  52,063  50,816  52,269  52,809  53,230  20,173  19,438  19,248 
Solvency Ratio
Financial leverage1 1.79 1.79 1.80 1.81 1.79 1.78 1.78 1.79 1.80 1.91 1.84 1.98 1.98 1.98 1.96 1.94 1.92 2.02 2.01 1.98 2.00 2.74 2.00 1.95
Benchmarks
Financial Leverage, Competitors2
Becton, Dickinson & Co. 2.25 2.55 2.45 2.46 2.43 2.47 2.47 2.57 2.53 2.58 2.61 2.91 2.95 3.03 3.21 3.35 3.24 3.42 3.61 3.74 3.73 3.95 3.65
Boston Scientific Corp. 1.97 2.18 2.20 2.76 2.58 2.58 2.41 2.46 2.53 2.73 2.72 2.46 2.54 2.54 2.69 2.73 2.87 2.74 2.87 2.84 2.60 2.53
Danaher Corp. 1.97 2.22 2.05 1.89 1.66 1.64 1.70 1.72 1.77 1.73 1.77 1.81 1.86 1.90 1.97 1.78 2.06 1.97 2.04 2.15 1.53 1.55
Intuitive Surgical Inc. 1.16 1.16 1.18 1.18 1.17 1.17 1.17 1.17 1.17 1.17 1.22 1.14 1.16 1.16 1.12 1.11 1.12 1.12 1.14 1.14 1.15 1.15
Stryker Corp. 2.47 2.24 2.36 2.16 2.21 2.22 2.32 2.24 2.28 2.40 2.23 2.06 2.12 2.11 2.14 2.16 2.26 2.23 1.91 1.88 1.98 1.99
Thermo Fisher Scientific Inc. 2.06 2.05 1.97 1.93 2.02 2.01 2.04 2.05 2.10 2.17 2.23 2.27 2.08 2.12 2.13 2.22 1.99 2.05 1.92 1.97 2.02 2.10
UnitedHealth Group Inc. 3.03 3.32 3.02 3.16 3.15 3.12 2.94 3.02 3.20 3.27 2.91 3.10 3.20 3.27 3.21 3.28 3.29 3.35 3.29 3.27 2.77 2.81

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

1 Q4 2020 Calculation
Financial leverage = Total assets ÷ Shareholders’ equity
= 90,689 ÷ 50,737 = 1.79

2 Click competitor name to see calculations.

Solvency ratio Description The company
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. Medtronic PLC’s financial leverage ratio decreased from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Interest Coverage

Medtronic PLC, interest coverage calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
Selected Financial Data (US$ in millions)
Net income (loss) attributable to Medtronic 646  1,915  1,364  864  1,172  1,269  1,115  1,075  1,460  (1,389) 2,017  1,016  1,163  821  1,115  929  1,103  1,095  520  820  (1) 977  828  871 
Add: Net income attributable to noncontrolling interest (7) 13  10  (3) (4) (7) (1) (4) —  —  —  —  —  —  —  —  — 
Add: Income tax expense (434) (340) (77) 100  110  99  235  103  260  2,419  (285) 186  271  147  101  59  31  84  563  120  188  217  194  212 
Add: Interest expense 162  156  165  609  718  243  241  242  317  270  273  286  290  268  264  272  481  275  324  306  299  176  94  97 
Earnings before interest and tax (EBIT) 367  1,735  1,459  1,586  2,010  1,613  1,596  1,422  2,042  1,297  2,001  1,481  1,725  1,235  1,476  1,260  1,615  1,454  1,407  1,246  486  1,370  1,116  1,180 
Solvency Ratio
Interest coverage1 4.71 4.12 3.84 3.76 4.60 6.40 5.94 6.14 5.95 5.81 5.77 5.34 5.21 4.35 4.49 4.24 4.13 3.81 4.08 4.82 6.23
Benchmarks
Interest Coverage, Competitors2
Becton, Dickinson & Co. 2.54 2.86 2.42 2.84 3.34 3.52 3.48 2.66 2.59 1.05 1.67 2.87 2.43 4.98 4.89 3.77 4.20 3.18 2.84 2.99 4.02 6.57 9.18
Boston Scientific Corp. 0.84 1.56 2.45 3.76 5.22 6.38 6.90 6.81 6.20 5.08 5.07 4.47 4.23 2.10 1.76 -0.06 -2.70 -0.31 -1.29
Danaher Corp. 20.00 25.33 31.44 34.20 29.52 24.77 21.92 21.12 20.86 19.99 19.06 18.34 16.31 15.04 15.16 14.42 15.68 19.13 21.42
Thermo Fisher Scientific Inc. 15.98 33.39
UnitedHealth Group Inc. 13.89 11.40 11.55 11.63 12.08 12.32 12.39 12.61 12.80 12.86 12.82 12.58 12.41 12.27 12.12 11.53 11.43 12.62 13.95

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

1 Q4 2020 Calculation
Interest coverage = (EBITQ4 2020 + EBITQ3 2020 + EBITQ2 2020 + EBITQ1 2020) ÷ (Interest expenseQ4 2020 + Interest expenseQ3 2020 + Interest expenseQ2 2020 + Interest expenseQ1 2020)
= (367 + 1,735 + 1,459 + 1,586) ÷ (162 + 156 + 165 + 609) = 4.71

2 Click competitor name to see calculations.

Solvency ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Medtronic PLC’s interest coverage ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.